About Atropos Therapeutics

Atropos Therapeutics Inc. is a biopharmaceutical company focused on discovering and developing drugs against aging disorders and cancer using its proprietary senescence technology. Our pipeline is preclinical stage and is NIH-funded. We are a relatively new company and welcome investors and colleagues to join our mission.